Over the entire cohort of BC patients, the overall survival seemed to be influenced by AKT1 (p = 0.02) and AKT2 expression levels (p = 0.03), as shown in Figures 5(a) and 5(b). This evidence concerns the gene AKT1 and breast cancer.